Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III
This article is from
The Cancer Letter
archive.
Vol. 33 No. 12 | December 31, 2010
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Contract Awards Sole Source Negotiations
January 13, 1978
TCL Archive
NCI Advisory Group, Other Cancer Meetings
August 19, 1983
TCL Archive
NTP Board Okays Contract Concepts
July 10, 1981
TCL Archive
Funding Opportunities
November 2, 2002
TCL Archive
Still Misperceptions On Hill About CRADA Between NCI, BMS
March 13, 1992
TCL Archive
NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”
October 23, 1981